Valve-in-Valve

Add this Moment to your Passport

Learn from this moment and keep it forever.
FREE
Add To Passport

Preview

Summary

Image title

Valve-in-Valve

Coronary obstruction is three- to fourfold more common after TAVI in degenerated surgical bioprostheses compared with native valve TAVI.15 Recently, Dvir and colleagues reported a coronary obstruction incidence of 3.5 % of patients.15 The main predisposing factor in the setting of aortic valve-in-valve procedures is the proximity of the coronary ostia to the anticipated final position of the displaced bioprosthetic leaflets after THV implantation. Therefore, predisposing factors for coronary obstruction may include a supra-annular bioprosthetic valve, a narrow and low-lying sinotubular junction, bulky bioprosthetic leaflets, low-lying coronaries in narrow aortic root and reimplanted coronaries.15 Bearing these concepts in mind, it appears logical that stentless bioprosthetic valves or those that are internally stented (eg, Mitroflow, Sorin; Trifecta, St Jude Medical) may be at a higher risk because the leaflets of these bioprostheses may extend outward in a tubular fashion after valve implantation beyond the surgical device frame (see Figure 5).15,16 In this setting, meticulous fluoroscopic and cardiac MDCT assessment may identify most cases at risk.16

Loading Simple Education